Kwangdong Pharmaceutical (009290) looked back on its growth and pledged a new push forward as it marked its 63rd anniversary. The company plans to build a foundation for sustainable growth by strengthening its pharmaceutical expertise and financial soundness while carrying out its social responsibility.
Kwangdong Pharmaceutical said on the 19th that it held a ceremony to mark the 63rd anniversary of its founding, reviewing its achievements and sharing its vision for the future.
The ceremony was attended by Chairman and Chief Executive for Vision Chey Sung-won and President and Chief Executive for Management Park Sang-young, along with employees of Kwangdong Pharmaceutical and its affiliates. Attendees reflected on the meaning of the challenges and innovation of the past 63 years and committed to securing new growth drivers in a rapidly changing business environment.
In a commemorative address, Chey cited pharmaceutical expertise and social responsibility as core values for the company's continued growth. "On the strength of our expertise as a pharmaceutical company and our solid internal foundation, we must remake ourselves as a company that fulfills its social responsibility," the chairman said. "Let us use the history of challenge and innovation of the past 63 years as a stepping stone and move toward the future together, each in our own place."
The event also included an awards ceremony recognizing employees who contributed to the company's growth and development. Park personally presented awards to about 160 recipients, commending their dedication and hard work.
The awards included the Outstanding Kwangdong Employee Award for those who delivered exceptional work performance, the Good Colleague Award for employees who practiced cooperation and mutual benefit with co-workers, the Long Service Award for employees with five or more years of service, and the Core Values Award for those who put the company's core values into practice.
Kwangdong Pharmaceutical said it will use the anniversary ceremony as an occasion to strengthen its fundamental competitiveness as a pharmaceutical company, drawing on the experience and capabilities accumulated over the past 63 years, and to build a foundation for sustainable future growth together with its employees.